HLA Protein Technologies Inc.
HLA Protein Technologies develops and manufactures validated soluble HLA Class I & II molecules and related services — quantitative peptide binding, epitope mapping, immune-target validation, and transplant antibody assay development for the development of immunotherapeutics and vaccines.
Creative Diagnostics
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. In [...]
ClinChoice
ClinChoice is a recognized and highly respected mid-size, global, full-service contract research organization (CRO) specializing in clinical development, post-marketing, and functional service support.
Standard BioTools
Standard BioTools provides an established portfolio of essential, standardized technologies that empower customers to scale and accelerate their life sciences research.
AxiomBio, Inc.
Axiom provides accurate, affordable predictive models that integrate cell-based toxicity data with clinical outcomes for precise ML/AI-driven risk assessments.
Maxis Clinical Sciences
A dynamic management consulting firm for pharma & life sciences innovators. With 3K+ successful projects and 30+ global clients, we deliver expert consulting, innovative patient-centric solutions & workforce strategies. Our mission: to drive healthcare transformation through novel drugs, therapies and digital breakthroughs.
Volition
Volition is a leading epigenetics biomarker company, renowned for its proprietary liquid biopsy immunoassay approach to profiling nucleosomes.
chimera biotec GmbH
Chimera Biotec provides ligand binding PK / PD / ADA / nAB assays, focused on ultra sensitive immunoassays.
Self Care Catalysts, an Alira Health Company
Self Care Catalysts' Health Storylines Platform is a trusted companion for patients throughout their journey, generating real world evidence along the way.
Precision for Medicine
Precision for Medicine is an industry-leading global CRO, specifically designed to apply a biomarker-focused, precision medicine approach to therapeutic development.
HealthCore, Inc.
HealthCore is finding evidence and truth at the core of healthcare. As a wholly owned, independently operating subsidiary of Anthem, Inc., we utilize a powerful research ecosystem of expertise, relationships, and data to generate the evidence needed to improve healthcare.
OM1
With specialization in chronic conditions, OM1 leverages its extensive, specialty clinical networks and an artificial intelligence (AI) platform to offer enriched health care datasets, research analytics, data modeling, decision support, and retrospective and prospective clinical studies.
ICON
ICON is a global provider of consulting, and outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. We focus our innovation on the factors that are critical to our clients - reducing time to market, reducing cost and increasing quality.
PHAR
PHAR (Partnership for Health Analytic Research) brings together experienced methodologists and trained clinicians to produce high-quality real-world evidence that unlocks the hidden value of our clients’ innovative products.
Actu-Real
Actu-Real combines cross-functional skillsets to provide solutions to quality, cost and access challenges in healthcare for pharmaceutical cos, insurers and healthcare providers.
